Shrirang Karve

机构：Sanofi (United States) · ORCID：0000-0002-9433-3089

发表论文 44 篇 · 总被引 1376 次 · h-index 19

代表论文

• Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis (2011 · Biomaterials · 被引 173)
• Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system (2016 · Gene Therapy · 被引 159)
• Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery (2012 · Proceedings of the National Academy of Sciences · 被引 150)
• Folate-Targeted Polymeric Nanoparticle Formulation of Docetaxel Is an Effective Molecularly Targeted Radiosensitizer with Efficacy Dependent on the Timing of Radiotherapy (2011 · ACS Nano · 被引 124)
• Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza (2021 · npj Vaccines · 被引 122)
• Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity (2014 · Nanoscale · 被引 99)